The association between multiple sclerosis and infection with Epstein-Barr virus and retrovirus

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Haahr, Sven ^a   Munch, Mette ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

B lymphoblastoid cell line; Dual infection; Endogenous retrovirus; Epidemiology; Interaction; Multiple sclerosis

Indexed keywords

B LYMPHOBLAST; CONFERENCE PAPER; EPSTEIN BARR VIRUS; HUMAN; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RETROVIRUS; VIRUS INFECTION; VIRUS PARTICLE;

ANTIGENS, VIRAL; ENDOGENOUS RETROVIRUSES; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; MULTIPLE SCLEROSIS;

HUMAN HERPESVIRUS 4; UNIDENTIFIED RETROVIRUS;

EID: 0034048067     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Bangham CRM, Nightingale S, Cruickshang JK, Daenke S (1989). PCR analysis of DNA from multiple sclerosis patients for the presence of HTLV-I. Science 246: 821.
2. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD (1983). Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 40: 406-408.
3. Bray PF, Culp KW, McFarlin DE, Panitch HS, Torkelsen RD, Schlight JP (1992). Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology 42: 278-282.
4. Charcot JM (1868). Histologie de la sclerose en plaque. Gaz Hosp (Paris) 41: 551-554.
5. Christensen T, Dissing Sorensen P, Riemann H, Hansen HJ, Møller-Larsen A (1998). Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 352: 1033.
6. Compston DAS, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA (1986). Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 109: 325-344.
7. Evermann JF, Derse D, Dern PL (1991). Interactions between herpesvirus and retroviruses: implications in the initiation of disease. Microbial Pathogenesis 10: 1-9.
8. Fraser KB, Haire M, Millar JHD, McCrea S (1979). Increased tendency to spontaneous in-vitro lymphocyte transformation in clinically active multiple sclerosis. Lancet ii: 715-717.
9. Gale CR, Martyn CN (1995). Migrant studies in multiple sclerosis. Prog Neurobiol 47: 425-448.
10. Garson JA, Tuke PW, Giraud P, Paranhoe-Buccala G, Perron H (1998). Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351: 33.
11. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, de Thé G (1985). Antibodies to HTLV-I in patients with tropical spastic paraparesis. Lancet ii: 407-410.
12. Haahr S, Sommerlund M, Nielsen R, Møller-Larsen A, Hansen HJ (1991a). Just another dubious virus in cells from a patient with multiple sclerosis. Lancet i: 663-664.
13. Haahr S, Sommerlund M, Møller-Larsen A (1991b). Multiple sclerosis as a retroviral disease? Epidemiological consideration in relation to HTLV-I epidemiology. Neuroepidemiology 10: 232-235.
14. Haahr S, Sommerlund M, Møller-Larsen A, Mogensen S, Andersen HMK (1992). Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus? Neuroepidemiology 11: 299-303.
15. Haahr S, Koch-Henriksen N, Møller-Larsen A, Eriksen LS, Andersen HMK (1995). Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Multiple Sclerosis 1: 73-77.
16. Haahr S, Munch M, Christensen T, Møller-Larsen A, Hvas J (1998). Cluster of multiple sclerosis patients from Danish community. Lancet 349: 923.
17. Koprowski H, deFreitas EC, Harper ME, Sandberg-Wollheim M, Sheremata WA, Robert-Guroff M, Saxinger CW, Feinberg MB, Womg-Staal F, Gallo RC (1985). Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature 318: 154-160.
18. Kurtzke JF (1993). Epidemiological evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6: 382-427.
19. Larsen PD, Bloomer LC, Bray PF (1985). Epstein-Barr virus nuclear antigen and viral capsid antigen antibody titers in multiple sclersosis. Neurology 35: 435-438.
20. Lindberg C, Andersen O, Vahlne A, Dalton M, Rumaker B (1991). Epidemiological investigations of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 10: 62-65.
21. Marié P. (1884). Sclérose en plaques et maladies infectueuses. Prog Med 12: 287-289.
22. Martyn CN (1991). The epidemiology of multiple sclerosis. In: McAlpin's Multiple Sclerosis. Matthews WB (ed). Churchill Livingston: Edinburgh, London, Melbourne and New York. pp 3-40.
23. Martyn CN, Cruddas M, Compston DAS (1993). Symptomatik Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psych 56: 167-168.
24. Munch M, Møller-Larsen A, Christensen T, Morling N, Hansen HJ, Haahr S (1995). B-lymphoblastoid cell-lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. Multiple Sclerosis 1: 78-81.
25. Munch M, Riisom K, Christensen, Møller-Larsen A, Haahr S (1998a). The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients? Acta Neurol Scand 97: 171-174.
26. Munch M, Hvas J, Christensen T, Møller-Larsen A, Haahr S (1998b). A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 98: 395-399.
27. Myhr KM, Riise T, Barren-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H (1998). Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 64: 539-542.
28. Norrby E (1978). Viral antibodies in multiple sclerosis. Prog Med Virol 24: 1-39.
29. Operskalski EA, Visscher BR, Malmgren RM, Detels R (1989). A case-control study of multiple sclerosis. Neurology 39: 825-839.
30. Perron H, Geny C, Laurent A, Mouriquand C, Pellet I, Perret J, Seigneurin JM (1989). Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 140: 551-561.
31. Perron H, Lalande B, Gratacap B, Laurent A, Geny C, Mallaret M, Schuller E, Stroebner P, Seigneurin JM (1991). Isolation of retrovirus from patients with multiple sclerosis. Lancet 337: 862-863.
32. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B and The Collaborative Research Group on Multiple Sclerosis (1997). Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci 94: 7583-7588.
33. Richardson JH, Wucherpfenning KW, Ende N, Rudge P, Dalgleish AG, Hafler DA (1989). PCR analysis of DNA from multiple sclerosis patients for the presence of HTLV-I. Science 246: 821-823.
34. Riise T, Grønning M, Klauber MR, Barrett-Connor E, Nyland H, Albrectsen G (1991). Clustering of residence of multiple sclerosis patients at age 13-20 years in Hordeland, Norway. Am J Epidemiol 133: 932-939.
35. Riise T (1997). Cluster studies in multiple sclerosis. Neurology 49 (suppl 2): S27-S32.
36. Sawcer S, Robertson N, Compston (1997). Genetic epidemiology of multiple sclerosis. In: Multiple Sclerosis: Clinical Challenges and Controversies. Thompson AL, Polman C, Hohlfeld R (eds). Martin Dunitz, London. pp 13-29.
37. Shaw CM, Alvord Jr EC (1987). Multiple sclerosis beginning in infancy. J Child Neurol 2: 252-256.
38. Sommerlund M, Pallesen G, Møller-Larsen A, Hansen HJ, Haahr S (1993). Retrovirus-like particles in an Epstein-Barr virus producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand 87: 71-76.
39. Sumaya CV, Myers LW, Ellison GW (1980). Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 37: 94-96.
40. Sumaya CV, Myers LW, Ellison GW, Ench Y (1985). Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17: 371-377.
41. Warner HB, Carp RI (1988). Multiple sclerosis aetiologyan Epstein-Barr virus hypothesis. Med Hypothesis 25: 93-97.